0001209191-22-060278.txt : 20221207 0001209191-22-060278.hdr.sgml : 20221207 20221207200602 ACCESSION NUMBER: 0001209191-22-060278 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221205 FILED AS OF DATE: 20221207 DATE AS OF CHANGE: 20221207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Charlton Ralph William III CENTRAL INDEX KEY: 0001919397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 221451252 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 294-1687 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-05 0 0001683553 SPRUCE BIOSCIENCES, INC. SPRB 0001919397 Charlton Ralph William III C/O SPRUCE BIOSCIENCES, INC. 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 DALY CITY CA 94104 0 1 0 0 Chief Medical Officer Restricted Stock Units 0.00 2022-12-05 4 A 0 127000 0.00 A Common Stock 127000 127000 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the "Annual Vesting Date"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). /s/ Samir Gharib, Attorney-in-Fact 2022-12-07